by | Jan 5, 2021 | Feng, Jing, Hu, Hongzhen, Luo, Jialie, Yang, Pu
— Technology Description:
A team of researchers, led by Hongzhen Hu, at Washington University in St. Louis has developed a method of treating hair loss and alopecia by intradermal injection targeting TRPV4 activation. Using a small molecule TRPV4 agonist, a single intradermal injection is sufficient…
by | Dec 8, 2020 | Christopher, Matthew, DiPersio, John, Ley, Timothy, Petti, Allegra, Rettig, Michael
— Technology Description
Researchers at Washington University in St. Louis have discovered that interferon-gamma treatment could potentially prevent relapse after hematopoietic stem cell transplantation (HCT) treatment by making the cancer cells more visible to the donor immune cells. This technolog…
by | Sep 21, 2020 | Kaiko, Gerard, Liu, Ta-Chiang, Stappenbeck, Thaddeus
— Plasminogen activator inhibitor-1 (PAI-1) has been identified as a specific biomarker that is significantly elevated in patients with inflammatory bowel disease (IBD) and is correlated with disease severity. It could be used to both diagnose the disease (including ulcerative colitis and colonic Croh…
by | Sep 8, 2020 | Reck, Margaret, Schaffer, Jason, Wencewicz, Timothy
— Chemists from Washington University have discovered and characterized an enzyme pathway that could be harnessed as an efficient platform to produce peptide beta-lactone libraries for drug discovery. Beta-lactones are a family of molecules with a structure similar to penicillin and therefore could po…
by | Sep 3, 2020 | Curiel, David
— Background:
Viral vectors have been used for in vivo delivery of CRISPR/Cas9. However, it’s applications have been limited by the native tropism of the viral vector. To better utilize in vivo editing, methods must be developed to accomplish efficient, selective and coordinated delivery of CRI…